Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating biomarker for malignant pleural mesothelioma diagnosis: pay attention to study design.

Literature DB >> 27867540

Circulating biomarker for malignant pleural mesothelioma diagnosis: pay attention to study design.

Zhi-De Hu¹.

Abstract

Entities: Disease

Year: 2016 PMID： 27867540 PMCID： PMC5107517 DOI： 10.21037/jtd.2016.10.94

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

7 in total

Review 1. Biomarkers and prognostic factors for malignant pleural mesothelioma.

Authors: Paolo Vigneri; Federica Martorana; Livia Manzella; Stefania Stella
Journal: Future Oncol Date: 2015 Impact factor: 3.404

Review 2. Case-control and two-gate designs in diagnostic accuracy studies.

Authors: Anne W S Rutjes; Johannes B Reitsma; Jan P Vandenbroucke; Afina S Glas; Patrick M M Bossuyt
Journal: Clin Chem Date: 2005-06-16 Impact factor: 8.327

Review 3. The established and future biomarkers of malignant pleural mesothelioma.

Authors: V Panou; M Vyberg; U M Weinreich; C Meristoudis; U G Falkmer; O D Røe
Journal: Cancer Treat Rev Date: 2015-05-08 Impact factor: 12.111

Review 4. Management of malignant pleural mesothelioma-The European experience.

Authors: Isabelle Opitz
Journal: J Thorac Dis Date: 2014-05 Impact factor: 2.895

5. Diagnostic tests 2: Predictive values.

Authors: D G Altman; J M Bland
Journal: BMJ Date: 1994-07-09

6. Cancer biomarker discovery and validation.

Authors: Nicolas Goossens; Shigeki Nakagawa; Xiaochen Sun; Yujin Hoshida
Journal: Transl Cancer Res Date: 2015-06 Impact factor: 1.241

Review 7. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.

Authors: Weiquan Zhang; Xinshu Wu; Licun Wu; Weidong Zhang; Xiaogang Zhao
Journal: Ann Transl Med Date: 2015-08

7 in total

6 in total

Circulating biomarker for malignant pleural mesothelioma diagnosis: pay attention to study design.

Review 1. Biomarkers and prognostic factors for malignant pleural mesothelioma.

Review 2. Case-control and two-gate designs in diagnostic accuracy studies.

Review 3. The established and future biomarkers of malignant pleural mesothelioma.

Review 4. Management of malignant pleural mesothelioma-The European experience.

5. Diagnostic tests 2: Predictive values.

6. Cancer biomarker discovery and validation.

Review 7. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.

Review 1. Suggestions for designing studies investigating diagnostic accuracy of biomarkers.

2. Diagnostic accuracy of human epididymis secretory protein 4 for lung cancer: a systematic review and meta-analysis.

3. Plasma Long Non-Coding RNA RP11-438N5.3 Level for Non-Small Cell Lung Cancer Diagnosis [Letter].

Review 4. Diagnostic value of microRNAs for malignant pleural mesothelioma: A mini-review.

5. Serum exosomal long noncoding RNA CRNDE level for hepatocellular carcinoma diagnosis.

6. Serum miR-205-5p level for non-small-cell lung cancer diagnosis.